SPRAVATO®, an innovative medicinal treatment for major depressive disorder, has given hope to people who have not found success with various forms of pharmaceuticals and other treatments. Administered as a nasal spray with esketamine as the active ingredient, this medication works through NMDA receptors in the brain to help improve mood. Many patients considering this treatment are interested in knowing its success rate and whether it may be a good alternative for them.
The experienced providers at Prestige Clinic have treated patients with a variety of mental health challenges over the last decade. With extensive knowledge of innovative treatment options such as SPRAVATO®, our team is committed to offering individualized care and improving the quality of life for our patients. Let our providers answer all of your questions, including regarding the success rate of SPRAVATO® treatment.
SPRAVATO® is an NMDA receptor antagonist, a drug that affects certain pathways in the brain. It often provides quicker relief for major depressive disorder (MDD) than other conventional antidepressants, which may take several weeks to show their effectiveness.
SPRAVATO® is administered in a controlled environment under the supervision of a trained provider. Patients are monitored for about two hours after each session to ensure their safety and manage any potential side effects. SPRAVATO®’s success rate depends on the individual and their unique situation.
SPRAVATO® is generally prescribed for individuals with MDD who experience suicidal thoughts. To qualify for this treatment, patients must meet specific eligibility criteria determined by their provider. These include:
Your provider will perform a thorough evaluation to ensure SPRAVATO® is a safe and appropriate option for you. Our mental health professionals can also further explain SPRAVATO® treatment’s success rate.
The success rate of SPRAVATO® varies depending on individual circumstances. However, many patients report noticeable improvements in their symptoms, with some experiencing a reduction in depressive symptoms within the first few weeks of treatment.
SPRAVATO® is most effective when used in conjunction with other therapies, such as talk therapy or traditional antidepressants. This combination provides a holistic approach to treatment, allowing patients to benefit from the fast-acting nature of SPRAVATO® while addressing underlying issues.
SPRAVATO® treatments are conducted in a structured manner to ensure safety and comfort. Before starting treatment, your provider will review your medical history, current symptoms, and goals for therapy, allowing them to design a treatment plan tailored to your needs.
SPRAVATO® is administered as a nasal spray in a controlled setting. After receiving the medication, you will be monitored for about two hours, during which your vital signs and response to the medication will be assessed.
SPRAVATO® treatment typically begins with twice-weekly sessions for the first month. As progress is made, the frequency may decrease to once a week or every other week. Regular follow-up appointments with your provider ensure the treatment remains effective and adjustments are made as needed. The success rate of SPRAVATO® may also depend on an individual’s treatment schedule and personal factors.
The professionals at Prestige Clinic have spent over a decade helping patients navigate their mental health journeys. Patients trust us with their care for the following reasons:
Not only will our providers answer all of your questions regarding SPRAVATO®’s success rate, but they will also support you through every step of your treatment journey.
If you are considering SPRAVATO® for MDD, the team of professionals at Prestige Clinic is here to help. We will guide you through the process, explain the success rate of SPRAVATO® treatment, determine if it is right for you, and support you every step of the way. Call us today to schedule an appointment and take the first step toward relief from depression.